Abemaciclib
Prednisolone
Eli Lilly and CompanySmall moleculePhase 3Active
B
60/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 45/ 100
- Competitive Position
- 95/ 100
Competitive context
3 Active assets in the Prednisolone cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
CHLOROPTIC-P S.O.P. COMPONENT PREDNISOLONE University of Colombo | Phase 4 | BB |
PREDNISONE TABLETS Eli Lilly and Company | Phase 3 | B |
Abiraterone Acetate Eli Lilly and Company | Phase 3 | B |
Same molecule, other indications
Abemaciclib is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →